Volume 10,Issue 4
The Impact of Biochemical Tests on TP, ALB, and CHE Indicators in the Diagnosis of Liver Cirrhosis
Objective: To explore the value of serum total protein (TP), albumin (ALB), and cholinesterase (CHE) detection in the clinical diagnosis of liver cirrhosis. Method: From January to December 2024, the liver cirrhosis group (n = 20), viral hepatitis group (n = 20), and healthy control group (n = 20) that met the clinical diagnostic criteria were selected as the research subjects, and biochemical indicators were detected and analyzed. Result: The test data showed that there were statistically significant differences (p < 0.05) in the levels of TP, ALB, and CHE between the liver cirrhosis group and the healthy control group and the hepatitis group, and each indicator showed a gradient change characteristic among liver cirrhosis subgroups with different Child Pugh grades. The detection of TP, ALB, and CHE can provide important references for the differential diagnosis of cirrhosis and hepatitis, and can effectively evaluate the progression of cirrhosis. It has guiding significance for the development of diagnosis and treatment plans and prognosis judgment.
[1] Zhang Y, 2023, Application of AST and CHE Expression Levels in Biochemical Testing for the Diagnosis of Liver Cirrhosis Patients. Life Science Instruments, 21(S01): 332–332.
[2] Yang S, Wu M, 2023, Analysis of the Application Value of Blood Biochemical Testing Combined with Liver Function Testing in the Diagnosis of Chronic Hepatitis B Cirrhosis. Shanxi Medical Journal, 52(5): 382–385.
[3] Wu M, 2023, Analysis of the Detection Rate of Liver Function Biochemical Tests in Patients with Hepatitis and Cirrhosis. Chinese Journal of Frontier Health and Quarantine, 46(S02): 58–59.
[4] Wu X, Wang T, Du S, et al., 2022, Evaluation of the Diagnostic Value of Seven Non-Invasive Diagnostic Models for Chronic Hepatitis B Liver Fibrosis and Cirrhosis. Chinese Medical Journal, 19(10): 14–19.
[5] Li X, 2023, The Influence of Liver Function and Blood Biochemistry Tests on the Diagnosis of Chronic Hepatitis B Cirrhosis. Life Science Instruments, 21(S01): 350–350.
[6] Xu A, Zhang H, Wang W, 2022, The Application Effect of Liver Function Biochemical Testing in Patients with Hepatitis and Cirrhosis and Its Impact on CHE and TC Levels. Journal of Clinical Gastroenterology, 34(5): 368–371.
[7] Zhou X, Zhang J, Chen L, 2022, The Diagnostic Value of Clinical Biochemical Test Indicators Combined with Blood Routine for Patients with Viral Hepatitis. Shanxi Medical Journal, 51(24): 2864–2867.
[8] Zhang P, Zhu J, Yang B, et al., 2024, The Clinical Application Value of Serum Biochemical Markers Combined with APRI for Laboratory Diagnosis of Liver Diseases. Immunoassay and Clinical Labeling, 31(7): 1287–1291.
[9] Gu Y, Wang R, Deng J, et al., 2023, Differences in Biomarker Levels Before and After Liver Transplantation in Patients with Severe Hepatitis and Cirrhosis and Their Prognostic Evaluation Value. Journal of Laboratory Medicine, 38(11): 1044–1051.
[10] Zhang S, 2024, Preface to the Album “Biochemical Analysis” – Assisting in Clinical Diagnosis of Diseases. Applied Chemistry, 41(1): 1–2.